Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
08/1998
08/20/1998CA2280761A1 Benzimidazole derivatives
08/19/1998EP0759926B1 Process for producing arabino-nucleosides
08/19/1998CN1190972A Pyrmidine nucleoside derivatives
08/19/1998CN1190656A Process for separating thymidine from mixture
08/18/1998US5795977 Water soluble adenosine kinase inhibitors
08/18/1998US5795778 Using enzymatic rna compound
08/18/1998US5795756 Method and compounds for the inhibition of adenylyl cyclase
08/18/1998US5795721 High affinity nucleic acid ligands of ICP4
08/13/1998WO1998035048A2 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
08/13/1998WO1998034942A2 Dinucleotides and their use
08/13/1998WO1998034593A1 Method of treating dry eye disease with purinergic receptor agonists
08/12/1998EP0698610B1 Process for producing sialic acid derivative and novel sialic acid derivative
08/12/1998EP0487719B1 Process for the preparation of 9-beta-d-arabinofuranosyl-2-fluoroadenine 5'-phosphate
08/12/1998CN1190401A C-4' modified adenosine kinase inhibitor
08/11/1998US5792868 Process for producing acyclic nucleosides and process for separating purine nucleosides
08/11/1998US5792847 2' Modified Oligonucleotides
08/11/1998US5792844 Mimic and/or modulate the activity of wild-type nucleic acids
08/11/1998US5792841 Antiviral, antineoplastic agents
08/11/1998US5792839 Reacting glcosyl donor having anomeric sulfoxide group and glycosyl acceptor at low temperature
08/11/1998US5792756 Phosphonate nucleotide analog antiviral/antitumor agent for oral drug delivery
08/11/1998US5792752 Synergistic effect in cancer and leukemic cell growth inhibition when a site 1-selective compound is used in combination with a site 2-selective compound
08/11/1998US5792608 Nuclease stable and binding competent oligomers and methods for their use
08/06/1998WO1998033936A1 The use of nadph and nadh analogs in the measurement of enzyme activities and metabolites
08/06/1998WO1998033806A1 Base protecting groups and process for oligonucleotide synthesis
08/06/1998WO1998033492A1 Compounds and methods for therapeutic intervention in preventing diabetic complications
08/04/1998US5789608 Lipid soluble; diffuse into cells and tissue; viricides, anticancer agents
08/04/1998US5789576 Methylphosphonate dimer synthesis
08/04/1998US5789562 Nucleotide monomers containing 8-azapurin bases or a derivative thereof, their preparation and their use in making modified olignonucleotides
08/04/1998US5789416 Cardiovascular and nervous system disorders
08/04/1998US5789394 Viricides for cytomegalovirus using nucleotides
08/04/1998US5789391 Method of treating sinusitis with uridine triphosphates and related compounds
08/04/1998US5789163 Enzyme linked oligonucleotide assays (ELONAS)
08/04/1998US5789162 Methods of synthesizing diverse collections of oligomers
08/04/1998US5789160 Parallel selex
08/04/1998US5789157 Systematic evolution of ligands by exponential enrichment: tissue selex
08/04/1998CA2087425C 2'-fluorofuranosyl derivatives and novel method of preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides
07/1998
07/30/1998WO1998032762A1 Gemcitabine derivatives
07/29/1998EP0854877A1 Metallocene-phosphoramidite conjugates, process for their preparation and their use
07/29/1998EP0854874A1 Macrocyclic lactone compounds and their production process
07/29/1998EP0698032B1 Preparation of fluoro-nucleosides and intermediates for use therein
07/29/1998CN1189097A Dinucleotides useful for the treatment of lung disease
07/29/1998CN1188771A Heterocyclic radical, sugar radical polysubstituted pyrrodiazole-like compound and synthetic method thereof
07/28/1998US5786462 Genetic engineered enzyme inhibitors
07/28/1998US5786141 Electrogenerated chemiluminescence labels for analysis and/or referencing
07/28/1998CA2082527C Use of purine derivatives for anesthesia, analgesia and in vivo organ preservation
07/23/1998WO1998031374A1 Method of treating rhinoviral infections
07/23/1998WO1998031373A1 Method of treating herpes infections
07/23/1998CA2277230A1 Method of treating herpes infections
07/23/1998CA2277053A1 Method of treating rhinoviral infections
07/22/1998EP0853628A1 Photolabile 8-substituted cyclic nucleotide esters, methods of preparing them and their use
07/21/1998US5783690 Phosphitylating agents for preparing nucleoside phosphoramidites
07/21/1998US5783689 Antibacterial and antifungal nucleosides
07/21/1998US5783688 Treating aqueous methanolic solution of 2',3'-dideoxy-3'-fluorouridine with charcoal
07/21/1998US5783682 Oligonucleotide mimics having nitrogen-containing linkages
07/21/1998US5783679 Purine nucleoside modifications by palladium catalyzed methods and oligonucleotides containing same
07/21/1998US5783425 Amino and peptido modified enzymatic nucleic acid
07/21/1998CA2091732C A process for the preparation of 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine
07/21/1998CA1339965C Antiparasitic agents
07/21/1998CA1339964C Substituted adenine derivatives useful as therapeutic agents
07/16/1998WO1998030992A2 Fluorescent cyanine dyes
07/16/1998WO1998030720A1 Bioconjugation of oligonucleotides
07/16/1998WO1998030575A1 Bioconjugation of macromolecules
07/16/1998WO1998030223A1 Cytokine related treatments of disease
07/16/1998CA2322053A1 Novel nucleosides
07/16/1998CA2278158A1 Cytokine related treatments of disease
07/16/1998CA2277545A1 Bioconjugation of oligonucleotides
07/16/1998CA2277159A1 Bioconjugation of macromolecules
07/15/1998EP0852499A1 Therapeutic azide compounds
07/15/1998EP0509019B1 Treatment of human retroviral infections with 2',3'-dideoxyinosine
07/14/1998US5780617 Phosphorylation of a phosphatides with a nucleotides
07/14/1998US5780610 Oligonucleotide aptamers including complementary nonnatural nucleotide units
07/14/1998US5780585 Bacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic form
07/14/1998US5780442 Antibacterial agents
07/14/1998US5780228 High affinity nucleic acid ligands to lectins
07/14/1998CA2131372C Sugar derivatives of macrolides
07/09/1998WO1998029429A1 Method for the synthesis of nucleotide or oligonucleotide phosphoramidites
07/09/1998WO1998029108A2 Compositions and methods for restoring a normal pattern of imprinting to cells
07/08/1998EP0851866A1 Therapeutic compounds
07/08/1998EP0748806B1 PROCESS FOR PREPARING POLYMORPHS B AND C OF 1- 2,4-DICHLORO-BETA-[(7-CHLOROBENZO[b]THIEN-3-YL)METHOXY]PHENETYL]IMIDAZOLE MONONITRATE
07/07/1998US5777100 Increasing levels of adenosine, cardiovascular, ischemia
07/07/1998US5777092 Heteroatomic oligonucleoside linkages
07/07/1998US5776911 Use of (S)-adenosyl-l-methionine (same) and its physiologically tolerated salts for treating reperfusion damage caused by temporary focal ischemia
07/07/1998CA2117891C Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent
07/02/1998WO1998028319A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
07/02/1998WO1998028318A1 Therapeutic compounds
07/02/1998WO1998028317A2 Synthesis of nucleosides and polynucleotides
07/02/1998WO1998021362A3 Stabilized aqueous nucleoside triphosphate solution
07/02/1998CA2275964A1 Synthesis of nucleosides and polynucleotides
07/02/1998CA2275271A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
07/01/1998EP0850949A2 Novel derivatives for use in nucleic acid sequencing
07/01/1998EP0850248A1 Compositions and methods for the synthesis of organophosphorus derivatives
07/01/1998EP0850247A1 Pyrimidine nucleoside derivative
07/01/1998EP0850246A2 Pyrimidine nucleoside derivatives
07/01/1998CN1186496A Covalently linked oligonucleotide minor groove binder conjugates
06/1998
06/30/1998US5773607 Multistage process with reduction and cyclization for formation of enzyme inhibitors of adenosine deaminase as antitumor agents and anticarcinogenic agents and bactericides
06/30/1998US5773603 Method for treating allergic diseases with adenosine derivatives
06/30/1998US5773598 Systematic evolution of ligands by exponential enrichment: chimeric selex
06/30/1998US5773592 Pro drugs for selective drug delivery
06/30/1998US5773431 Administration of a 27-hydroxycholesterol or prodrug thereof as an anti-cancer agent
06/30/1998US5773423 A3 adenosine receptor agonists